nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—ABCB1—peripheral nervous system neoplasm	0.292	1	CbGaD
Clopidogrel—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0505	0.103	CbGbCtD
Clopidogrel—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0398	0.0812	CbGbCtD
Clopidogrel—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0382	0.078	CbGbCtD
Clopidogrel—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0318	0.065	CbGbCtD
Clopidogrel—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0278	0.0568	CbGbCtD
Clopidogrel—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0278	0.0568	CbGbCtD
Clopidogrel—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0267	0.0544	CbGbCtD
Clopidogrel—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0255	0.0519	CbGbCtD
Clopidogrel—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0216	0.0441	CbGbCtD
Clopidogrel—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0193	0.0394	CbGbCtD
Clopidogrel—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0183	0.0373	CbGbCtD
Clopidogrel—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0167	0.0341	CbGbCtD
Clopidogrel—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0167	0.034	CbGbCtD
Clopidogrel—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0161	0.0328	CbGbCtD
Clopidogrel—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0155	0.0316	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0145	0.0296	CbGbCtD
Clopidogrel—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0125	0.0254	CbGbCtD
Clopidogrel—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0119	0.0243	CbGbCtD
Clopidogrel—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0114	0.0233	CbGbCtD
Clopidogrel—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0111	0.0226	CbGbCtD
Clopidogrel—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0109	0.0222	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00743	0.0152	CbGbCtD
Clopidogrel—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00712	0.0145	CbGbCtD
Clopidogrel—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00652	0.0133	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00445	0.00908	CbGbCtD
Clopidogrel—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.000469	CcSEcCtD
Clopidogrel—Nausea—Topotecan—peripheral nervous system neoplasm	0.000102	0.000469	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000102	0.000468	CcSEcCtD
Clopidogrel—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000468	CcSEcCtD
Clopidogrel—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000102	0.000467	CcSEcCtD
Clopidogrel—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000101	0.000465	CcSEcCtD
Clopidogrel—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000101	0.000465	CcSEcCtD
Clopidogrel—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000101	0.000463	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.0001	0.000461	CcSEcCtD
Clopidogrel—Infection—Etoposide—peripheral nervous system neoplasm	0.0001	0.00046	CcSEcCtD
Clopidogrel—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.0001	0.00046	CcSEcCtD
Clopidogrel—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.0001	0.000459	CcSEcCtD
Clopidogrel—Nausea—Melphalan—peripheral nervous system neoplasm	0.0001	0.000459	CcSEcCtD
Clopidogrel—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000458	CcSEcCtD
Clopidogrel—Asthma—Epirubicin—peripheral nervous system neoplasm	9.96e-05	0.000457	CcSEcCtD
Clopidogrel—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	9.9e-05	0.000454	CcSEcCtD
Clopidogrel—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000452	CcSEcCtD
Clopidogrel—Abdominal pain—Vincristine—peripheral nervous system neoplasm	9.86e-05	0.000452	CcSEcCtD
Clopidogrel—Body temperature increased—Vincristine—peripheral nervous system neoplasm	9.86e-05	0.000452	CcSEcCtD
Clopidogrel—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	0.000451	CcSEcCtD
Clopidogrel—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	9.83e-05	0.000451	CcSEcCtD
Clopidogrel—Skin disorder—Etoposide—peripheral nervous system neoplasm	9.81e-05	0.00045	CcSEcCtD
Clopidogrel—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	9.76e-05	0.000448	CcSEcCtD
Clopidogrel—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000446	CcSEcCtD
Clopidogrel—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	9.7e-05	0.000445	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	9.6e-05	0.00044	CcSEcCtD
Clopidogrel—Bronchitis—Epirubicin—peripheral nervous system neoplasm	9.57e-05	0.000439	CcSEcCtD
Clopidogrel—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	9.55e-05	0.000438	CcSEcCtD
Clopidogrel—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	9.53e-05	0.000437	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	9.52e-05	0.000437	CcSEcCtD
Clopidogrel—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	9.46e-05	0.000434	CcSEcCtD
Clopidogrel—Hypotension—Etoposide—peripheral nervous system neoplasm	9.44e-05	0.000433	CcSEcCtD
Clopidogrel—Gastritis—Doxorubicin—peripheral nervous system neoplasm	9.43e-05	0.000433	CcSEcCtD
Clopidogrel—Pain—Cisplatin—peripheral nervous system neoplasm	9.43e-05	0.000432	CcSEcCtD
Clopidogrel—Neutropenia—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000427	CcSEcCtD
Clopidogrel—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.28e-05	0.000426	CcSEcCtD
Clopidogrel—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	9.27e-05	0.000425	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000424	CcSEcCtD
Clopidogrel—Asthma—Doxorubicin—peripheral nervous system neoplasm	9.21e-05	0.000423	CcSEcCtD
Clopidogrel—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.19e-05	0.000421	CcSEcCtD
Clopidogrel—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.15e-05	0.00042	CcSEcCtD
Clopidogrel—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.000418	CcSEcCtD
Clopidogrel—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	9.09e-05	0.000417	CcSEcCtD
Clopidogrel—Paraesthesia—Etoposide—peripheral nervous system neoplasm	9.07e-05	0.000416	CcSEcCtD
Clopidogrel—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000414	CcSEcCtD
Clopidogrel—Dyspnoea—Etoposide—peripheral nervous system neoplasm	9e-05	0.000413	CcSEcCtD
Clopidogrel—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.000412	CcSEcCtD
Clopidogrel—Asthenia—Vincristine—peripheral nervous system neoplasm	8.95e-05	0.00041	CcSEcCtD
Clopidogrel—Pneumonia—Epirubicin—peripheral nervous system neoplasm	8.93e-05	0.00041	CcSEcCtD
Clopidogrel—Vomiting—Dactinomycin—peripheral nervous system neoplasm	8.87e-05	0.000407	CcSEcCtD
Clopidogrel—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	8.86e-05	0.000406	CcSEcCtD
Clopidogrel—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	8.85e-05	0.000406	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.000404	CcSEcCtD
Clopidogrel—Rash—Dactinomycin—peripheral nervous system neoplasm	8.8e-05	0.000404	CcSEcCtD
Clopidogrel—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	8.75e-05	0.000401	CcSEcCtD
Clopidogrel—Renal failure—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.0004	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	8.72e-05	0.0004	CcSEcCtD
Clopidogrel—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.72e-05	0.0004	CcSEcCtD
Clopidogrel—Fatigue—Etoposide—peripheral nervous system neoplasm	8.71e-05	0.000399	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	8.7e-05	0.000399	CcSEcCtD
Clopidogrel—Stomatitis—Epirubicin—peripheral nervous system neoplasm	8.65e-05	0.000397	CcSEcCtD
Clopidogrel—Pain—Etoposide—peripheral nervous system neoplasm	8.64e-05	0.000396	CcSEcCtD
Clopidogrel—Constipation—Etoposide—peripheral nervous system neoplasm	8.64e-05	0.000396	CcSEcCtD
Clopidogrel—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000396	CcSEcCtD
Clopidogrel—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000396	CcSEcCtD
Clopidogrel—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000395	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000393	CcSEcCtD
Clopidogrel—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.56e-05	0.000392	CcSEcCtD
Clopidogrel—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.53e-05	0.000391	CcSEcCtD
Clopidogrel—Haematuria—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.000388	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	8.4e-05	0.000385	CcSEcCtD
Clopidogrel—Epistaxis—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000384	CcSEcCtD
Clopidogrel—Sinusitis—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000382	CcSEcCtD
Clopidogrel—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.32e-05	0.000382	CcSEcCtD
Clopidogrel—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.29e-05	0.00038	CcSEcCtD
Clopidogrel—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.00038	CcSEcCtD
Clopidogrel—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000379	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.26e-05	0.000379	CcSEcCtD
Clopidogrel—Dizziness—Vincristine—peripheral nervous system neoplasm	8.25e-05	0.000378	CcSEcCtD
Clopidogrel—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.23e-05	0.000377	CcSEcCtD
Clopidogrel—Rash—Alitretinoin—peripheral nervous system neoplasm	8.16e-05	0.000374	CcSEcCtD
Clopidogrel—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.15e-05	0.000374	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000373	CcSEcCtD
Clopidogrel—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.12e-05	0.000373	CcSEcCtD
Clopidogrel—Headache—Alitretinoin—peripheral nervous system neoplasm	8.11e-05	0.000372	CcSEcCtD
Clopidogrel—Renal failure—Doxorubicin—peripheral nervous system neoplasm	8.07e-05	0.00037	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	8.05e-05	0.000369	CcSEcCtD
Clopidogrel—Urticaria—Etoposide—peripheral nervous system neoplasm	8.02e-05	0.000368	CcSEcCtD
Clopidogrel—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000367	CcSEcCtD
Clopidogrel—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	8.01e-05	0.000367	CcSEcCtD
Clopidogrel—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.000366	CcSEcCtD
Clopidogrel—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.98e-05	0.000366	CcSEcCtD
Clopidogrel—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.98e-05	0.000366	CcSEcCtD
Clopidogrel—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000366	CcSEcCtD
Clopidogrel—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000366	CcSEcCtD
Clopidogrel—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	7.97e-05	0.000365	CcSEcCtD
Clopidogrel—Hepatitis—Epirubicin—peripheral nervous system neoplasm	7.97e-05	0.000365	CcSEcCtD
Clopidogrel—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.93e-05	0.000364	CcSEcCtD
Clopidogrel—Vomiting—Vincristine—peripheral nervous system neoplasm	7.93e-05	0.000364	CcSEcCtD
Clopidogrel—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.91e-05	0.000363	CcSEcCtD
Clopidogrel—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.000361	CcSEcCtD
Clopidogrel—Rash—Vincristine—peripheral nervous system neoplasm	7.86e-05	0.000361	CcSEcCtD
Clopidogrel—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.85e-05	0.00036	CcSEcCtD
Clopidogrel—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	7.85e-05	0.00036	CcSEcCtD
Clopidogrel—Haematuria—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000359	CcSEcCtD
Clopidogrel—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000358	CcSEcCtD
Clopidogrel—Headache—Vincristine—peripheral nervous system neoplasm	7.81e-05	0.000358	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	7.77e-05	0.000356	CcSEcCtD
Clopidogrel—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	7.75e-05	0.000355	CcSEcCtD
Clopidogrel—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000353	CcSEcCtD
Clopidogrel—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.69e-05	0.000353	CcSEcCtD
Clopidogrel—Visual impairment—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000352	CcSEcCtD
Clopidogrel—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000352	CcSEcCtD
Clopidogrel—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.54e-05	0.000346	CcSEcCtD
Clopidogrel—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000346	CcSEcCtD
Clopidogrel—Eye disorder—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000342	CcSEcCtD
Clopidogrel—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.44e-05	0.000341	CcSEcCtD
Clopidogrel—Tinnitus—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000341	CcSEcCtD
Clopidogrel—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.00034	CcSEcCtD
Clopidogrel—Nausea—Vincristine—peripheral nervous system neoplasm	7.41e-05	0.00034	CcSEcCtD
Clopidogrel—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000339	CcSEcCtD
Clopidogrel—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000338	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000338	CcSEcCtD
Clopidogrel—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.000336	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000334	CcSEcCtD
Clopidogrel—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	7.26e-05	0.000333	CcSEcCtD
Clopidogrel—Asthenia—Etoposide—peripheral nervous system neoplasm	7.25e-05	0.000332	CcSEcCtD
Clopidogrel—Angiopathy—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000332	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000332	CcSEcCtD
Clopidogrel—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.00033	CcSEcCtD
Clopidogrel—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	7.18e-05	0.000329	CcSEcCtD
Clopidogrel—Pruritus—Etoposide—peripheral nervous system neoplasm	7.15e-05	0.000328	CcSEcCtD
Clopidogrel—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000326	CcSEcCtD
Clopidogrel—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.01e-05	0.000321	CcSEcCtD
Clopidogrel—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.00032	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.00032	CcSEcCtD
Clopidogrel—Rash—Cisplatin—peripheral nervous system neoplasm	6.95e-05	0.000319	CcSEcCtD
Clopidogrel—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.94e-05	0.000319	CcSEcCtD
Clopidogrel—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.94e-05	0.000318	CcSEcCtD
Clopidogrel—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.91e-05	0.000317	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000316	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000315	CcSEcCtD
Clopidogrel—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000314	CcSEcCtD
Clopidogrel—Back pain—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000308	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000307	CcSEcCtD
Clopidogrel—Dizziness—Etoposide—peripheral nervous system neoplasm	6.68e-05	0.000306	CcSEcCtD
Clopidogrel—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.000306	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.000305	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.65e-05	0.000305	CcSEcCtD
Clopidogrel—Nausea—Cisplatin—peripheral nervous system neoplasm	6.55e-05	0.0003	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000296	CcSEcCtD
Clopidogrel—Vomiting—Etoposide—peripheral nervous system neoplasm	6.42e-05	0.000295	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000294	CcSEcCtD
Clopidogrel—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000294	CcSEcCtD
Clopidogrel—Rash—Etoposide—peripheral nervous system neoplasm	6.37e-05	0.000292	CcSEcCtD
Clopidogrel—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.36e-05	0.000292	CcSEcCtD
Clopidogrel—Headache—Etoposide—peripheral nervous system neoplasm	6.33e-05	0.00029	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.00029	CcSEcCtD
Clopidogrel—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000286	CcSEcCtD
Clopidogrel—Syncope—Epirubicin—peripheral nervous system neoplasm	6.22e-05	0.000285	CcSEcCtD
Clopidogrel—Leukopenia—Epirubicin—peripheral nervous system neoplasm	6.21e-05	0.000285	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000285	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000283	CcSEcCtD
Clopidogrel—Palpitations—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000281	CcSEcCtD
Clopidogrel—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.1e-05	0.00028	CcSEcCtD
Clopidogrel—Cough—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000278	CcSEcCtD
Clopidogrel—Nausea—Etoposide—peripheral nervous system neoplasm	6e-05	0.000275	CcSEcCtD
Clopidogrel—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.99e-05	0.000275	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000272	CcSEcCtD
Clopidogrel—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000271	CcSEcCtD
Clopidogrel—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000271	CcSEcCtD
Clopidogrel—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000271	CcSEcCtD
Clopidogrel—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.89e-05	0.00027	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000269	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.000264	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000264	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000264	CcSEcCtD
Clopidogrel—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000262	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.00026	CcSEcCtD
Clopidogrel—Oedema—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.00026	CcSEcCtD
Clopidogrel—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.00026	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000259	CcSEcCtD
Clopidogrel—Infection—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000258	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000257	CcSEcCtD
Clopidogrel—Shock—Epirubicin—peripheral nervous system neoplasm	5.57e-05	0.000255	CcSEcCtD
Clopidogrel—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000255	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.54e-05	0.000254	CcSEcCtD
Clopidogrel—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000252	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000251	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000251	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000251	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.45e-05	0.00025	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000249	CcSEcCtD
Clopidogrel—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.29e-05	0.000243	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000242	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.00024	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.00024	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000239	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000237	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.000236	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.14e-05	0.000236	CcSEcCtD
Clopidogrel—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.12e-05	0.000235	CcSEcCtD
Clopidogrel—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000233	CcSEcCtD
Clopidogrel—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000233	CcSEcCtD
Clopidogrel—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.000232	CcSEcCtD
Clopidogrel—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000229	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.9e-05	0.000225	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000224	CcSEcCtD
Clopidogrel—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000224	CcSEcCtD
Clopidogrel—Constipation—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000222	CcSEcCtD
Clopidogrel—Pain—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000222	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000219	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000217	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000216	CcSEcCtD
Clopidogrel—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000214	CcSEcCtD
Clopidogrel—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000214	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.000212	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000211	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000207	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000207	CcSEcCtD
Clopidogrel—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000206	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000205	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000205	CcSEcCtD
Clopidogrel—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000205	CcSEcCtD
Clopidogrel—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000205	CcSEcCtD
Clopidogrel—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000198	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000196	CcSEcCtD
Clopidogrel—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000191	CcSEcCtD
Clopidogrel—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000191	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.00019	CcSEcCtD
Clopidogrel—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.00019	CcSEcCtD
Clopidogrel—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000186	CcSEcCtD
Clopidogrel—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000184	CcSEcCtD
Clopidogrel—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000178	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000177	CcSEcCtD
Clopidogrel—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000172	CcSEcCtD
Clopidogrel—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000172	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.00017	CcSEcCtD
Clopidogrel—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000165	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000164	CcSEcCtD
Clopidogrel—Rash—Epirubicin—peripheral nervous system neoplasm	3.57e-05	0.000164	CcSEcCtD
Clopidogrel—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.57e-05	0.000164	CcSEcCtD
Clopidogrel—Headache—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000163	CcSEcCtD
Clopidogrel—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000159	CcSEcCtD
Clopidogrel—Nausea—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000154	CcSEcCtD
Clopidogrel—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000153	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000151	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000151	CcSEcCtD
Clopidogrel—Headache—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000151	CcSEcCtD
Clopidogrel—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000143	CcSEcCtD
